抑郁模型大鼠海马突触的差异蛋白质组学分析

目的通过抑郁模型大鼠海马突触的差异蛋白质组学分析,为抑郁症发病机制研究提供依据。方法根据糖水消耗基线值将40只健康雄性Sprague—Dawley大鼠随机分为慢性轻度不可预见性应激组和对照组（每组20只）。通过CUMS实验模式建立大鼠抑郁模型后,运用蔗糖密度梯度离心法提取两组大鼠的海马突触并用透射电镜进行检测。采用传统的双向凝胶电泳和基质辅助激光解析电离飞行时间串联质谱进行差异蛋白质组学分析。结果在行为学评价中CUMS组大鼠糖水消耗量和偏好度均降低（P〈0．01）,表明大鼠抑郁模型建立成功。通过结合双向凝胶电泳和质谱分析,共得到6个在CUMS组表达上调和10个在CUMS组表达下调的蛋白质,这些蛋白质的功能主要归为四类,即囊泡调节／递质释放／信号转导、能量代谢、细胞骨架、物质代谢。结论通过对抑郁模型大鼠海马突触的比较蛋白质组学分析及后续的蛋白质功能预测,发现了一些与突触传导功能障碍可能相关的蛋白质,从而为抑郁症发病机制的研究提供了有价值的线索。     

盐酸戊乙奎醚对大鼠感染性脑水肿AQP4表达的影响

目的：研究盐酸戊乙奎醚对感染性脑水肿保护作用的机制。方法：采用左颈内动脉注射脂多糖复制大鼠感染性脑水肿模型,将84只雄性SD大鼠随机分为对照组（C组）、水肿组（I组）、盐酸戊乙奎醚治疗组（P组）。检测6h、12h、24h、48h时各组大鼠脑组织含水量、病理形态;脑组织SOD活性、MDA含量;免疫组化法及RT—PCR法检测AQP4蛋白分布与AQP4mRNA含量。结果：（1）与C组相比,I组、P组脑含水量、MDA含量均升高,同时SOD活性、AQP4蛋白、AQP4mRNA表达均减少（P〈0．01）。与对应时间点P组相比,I组脑含水量、MDA含量均升高,同时SOD活性、AQP4蛋白、AQP4mRNA表达均减少,于24h达高峰,48h仍在较高水平（P〈0．01）。（2）脑组织光镜检查：I组大鼠脑组织损伤严重,P组损伤明显减轻。结论：盐酸戊乙奎醚能在一定程度上可减轻感染所致的脑组织损伤,上调AQP4表达,对脑水肿有一定治疗作用,其机制可能与抗氧化作用有关。     

单纯及丙泊酚联合电休克对抑郁大鼠海马TNF—α表达的影响

目的探讨单纯电休克及丙泊酚联合电休克对抑郁大鼠电休克治疗效果及海马内TNF-α表达的影响。方法50只成年Wistar大鼠随机分为5组（n=10）：正常对照组（C组）、抑郁组（D组）、单纯丙泊酚组（DP组）、单纯电休克组（E组）、丙泊酚联合电休克组（M组）。C组正常饲养,其余采用经典的慢性不可预见性应激法建立抑郁模型。建模成功后,E组直接行电休克治疗,M组腹腔注射丙泊酚90mg／kg,麻醉产生效应后行电休克治疗,每日进行以上处理1次,连续7日。以Open—field法和糖水消耗实验进行行为学评分。实验完成后处死大鼠,用免疫组化染色法检测TNF—α受体蛋白的表达;ELISA法海马TNF-α的含量,RT-PCR法测海马TNF—α mRNA表达。结果E组和M组大鼠的行为学评分高于D组和DP组,且M组高于E组（P〈0．05）;D组和DP组海马内TNF-α含量以及mRNA的表达高于其它各组（P〈0．05）,M组海马内TNF—α含量以及mRNA的表达低于E组（P〈0．05）,与C组差异无统计学意义（P〉0．05）;D组和DP组海马区TNF-α受体表达量低于C组（P〈0．05）,M组的表达量接近于C组,但高于E组（P〈0．05）。结论慢性应激使大鼠海马内TNF—α含量升高及其受体表达下调,从而产生抑郁症。丙泊酚可以改善电休克抑郁症状可能与进一步下调抑郁大鼠海马内TNF—α的含量和上调其受体表达有关。     

两种新生大鼠皮质发育障碍模型的差异基因表达谱研究

目的研究两种不同的方法构建皮质发育障碍(DCDs)动物模型中的共同差异表达基因,为进一步研究DCDs形成机制提供基因水平筛选的研究平台。方法用两种方法制备DCDs模型:①射线损伤模型(射线组):采用剂量为1.45 Gy的γ射线照射妊娠15 d的SD大鼠制作子代大鼠DCDs模型;②卡莫司汀(BCNU)药物损伤模型(药物组):妊娠15 d的SD大鼠,腹腔注射BCNU制作子代大鼠DCDs模型。同时设正常对照组。对两种DCDs模型的子代新生鼠(P0)全脑做基因芯片扫描,结果与正常对照组比较,获得两种模型共有的差异基因。结果射线组大鼠与正常比较得到170个差异基因,其中25个上调,145个下调;药物组大鼠与正常比较得到259个差异基因,其中67个上调,192个下调。两组重合的基因共54个,其中3个上调,51个下调。结论皮质发育障碍是一个复杂的病理过程,本实验运用基因芯片技术,对两种不同方法构建的DCDs模型进行了研究,获得两种DCDs模型共有的基因差异表达谱,为进一步研究DCDs形成机制提供了分子生物学平台。     

蛋白质组学在药物及疾病标志物研究中的应用进展

蛋白质组学提供了整体水平研究蛋白质的表达、翻译后修饰,以及蛋白质的功能的思路,由此获得蛋白质水平上的关于疾病发生、细胞代谢等过程的全面认识,逐渐被广泛应用于药物及生物标志物研究中.本文介绍了蛋白质组学的经典技术路线和新策略,并综述了其在药物及疾病标志物研究中应用进展.     

早期母子隔离应激对大鼠学习记忆能力的影响

目的探讨早期母子隔离应激对幼鼠学习记忆能力的影响。方法30只SD新生大鼠用于实验,实验随机分成3组,正常对照纽、母子隔离15分钟纽、母子隔离3小时纽。在生后40天,三组大鼠进行Morris水迷宫及记录海马脑片长时程增强电位（LTP）实验。结果Morris水迷宫测试,与正常组比较母子隔离3h组大鼠寻找平台需要的潜伏期延长（P〈0．05）,而母子隔离15分钟组大鼠寻找平台需要的潜伏期与正常组比较则无明显变化（P〉0．05）;海马脑片长时程增强电位提示：正常对照组条件刺激（CS）前后fEPSP斜率变化率为：64．7±22．9％;母子隔离3h组为：35．3±14．2％,低于正常组（P〈0．01）;母子隔离15min组为：66．3±29．7％,与正常组比较无显著性意义（P〉0．05）。结论幼鼠生后早期过度的应激导致大鼠的学习记忆能力减弱。     

表观遗传基因沉默研究新进展

美国弗吉尼亚联邦大学Massey癌症中心的研究人员确定出了一种蛋白质在血红蛋白基因沉默中的作用。这种蛋白将可能成为在分子水平上治疗遗传性血液疾病如镰刀细胞贫血症和β-地中海贫血症的一个非常有潜力的靶标。这项研究的结果公布在4月的PNAS（美国科学院院刊）中。研究人员首次发现蛋白质MBD2蛋白通过甲基化作用（DNA的一种化学修饰过程）介导胎儿gamma球蛋白基因沉默。     

解聚复肾宁对糖尿病肾病大鼠TNF—OL、MCP-1的影响

目的观察解聚复肾宁（Jiejufushenning,JJFSN）对糖尿病（Diabetes mellitus,DM）大鼠肾组织肿瘤坏死因子-α（Tumorneerosisfactor-alpha,TNF-α）、单核细胞趋化蛋白-1（Monocyte chemoattractant protein-1,MCP-1）和血清TNF-α的影响,探讨其肾保护作用机制。方法腹腔注射链脲佐菌素（Streptozotocin,STZ）建立SD大鼠DM模型,将成模DM大鼠随机分为3组：DM模型组（B组）、JJFSN组（C组）、厄贝沙坦（Irbesartan）组（D组）,另设正常对照组（A组）。采用相应干预措施处理12周。常规方法测定12周末各组大鼠空腹血糖（FBG）、血尿素氮（BUN）、血肌酐（Scr）、肾重／体重（KW／BW）、24h尿蛋白（24huFro）;放免法测血清TNF-α含量：免疫组织化学方法测肾组织TNF—Ot、MCP-1的表达;PAS染色评估细胞外基质;电镜观察肾组织超微结构改变。结果与A组相比．B组大鼠FBG、BUN、Scr、KW／BW、24huPro及血清TNF-α升高（P〈0．05）,肾组织TNF—Ot、MCP-1表达明显增高（P〈0．05）;肾组织超微结构明显异常;C组和D组上述指标显著改善（P〈0．05）,肾组织超微结构异常改善。结论竹FSN能延缓DM大鼠肾损害进程,其机制可能与抑制TNF-α、MCP-1上调有关。     

姜黄素逆转人结肠癌细胞HCT-8／VCR的双向凝胶电泳技术的建立及优化

目的建立并优化姜黄素逆转人结肠癌细胞HCT-8／VCR蛋白质纽的双向电泳技术。方法姜黄素作用于人结肠癌细胞HCT-8／VCR,提取蛋白质。对双向凝胶电泳中蛋白质样品的处理,蛋白上样量,IPG胶条的选择,以及聚焦条件等进行调整和每化。结果采用瓶内刮取的方法裂解细胞,pH3-10NL的胶条,上样量200ug,延长除盐时间,聚焦60000伏小时,可以得到分辨率较高、重复性较好的双向电泳图谱。结论初步建立了分辨率较高且重复性较好的姜黄素逆转人结肠癌细胞HCT-8／VCR蛋白质双向凝胶电泳图谱。     

成年大鼠脊髓损伤后Sonic Hedgehog信号通路成分的动态表达

目的观察Sonic Hedgehog(Shh)信号通路中Shh、Gli-1在成年大鼠脊髓损伤后的动态表达,探讨Shh信号通路对大鼠脊髓损伤后的调控作用。方法将64只健康SD大鼠随机分为正常组(n=8),假手术组(n=8),脊髓损伤12h、1d、3d、7d、14d和21d组(n=8),共8组。构建大鼠脊髓损伤模型,观察损伤后大鼠行为学的改变,并应用实时荧光定量PCR技术(Real-Time Quantitative PCR)和蛋白免疫印迹法(Western Blotting)检测Shh、Gli-1 mRNA和相关蛋白表达水平的变化。结果行为学观察表明,大鼠脊髓损伤后运动功能下降,RT-PCR和免疫印迹法表明,Shh、Gli-1在正常组织少量表达,脊髓损伤后Shh、Gli-1表达均明显增高,损伤后第7天达到峰值,损伤21天后仍有高水平的表达。结论脊髓损伤可以上调Shh信号通路成分的表达并表现出一定的动态变化规律,提示Shh信号通路可能参与了脊髓损伤后神经细胞的调控作用。     

Evidence for suppression of immune function by insulin-like growth factor-1 in dwarf rats in vivo

These studies were undertaken to investigate the effects of increasing or decreasing IGF-1 levels on aspects of immune function in rats. Female dwarf rats were treated with recombinant human IGF-1 or with a potent sheep anti-IGF-serum. Body weight, thymus weight and spleen weight increased with IGF-1 treatment (p<0.001), while there was no effect of anti-IGF-1 treatment when compared with the appropriate normal sheep serum (NSS) treated controls. IGF-1 treatment significantly decreased WBC and RBC counts, but increased the ratio of CD4⁺:CD8⁺ T-cells. Anti-IGF-1 serum had no effect on these parameters compared with NSS. However anti-IGF-1 was associated with increased T-cell numbers, decreased natural killer cells, and enhancement of the animals' ability to produce specific IgG in response to injection of keyhole limpet haemocyanin (KLH). These results indicate that IGF-1 may suppress immune function although increasing the size of immune organs such as spleen.These studies were part of an M.Sc. at the University of Waikato, Hamilton, New Zealand.     

Immunochemical study of protein anomalies in platelets of patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome]

Crossed immunoelectrophoresis of "Triton X-100" solubilized proteins from (125I) iodinated normal and abnormal (Bernard-Soulier and thrombasthenic) platelets was performed using rabbit antibodies raised against whole, normal platelets. In Bernard-Soulier platelets neither of the two surface oriented forms of GP I, glycocalicin and glycoprotein Ib (band 13) were detected. In two patients with type I thrombasthenia, the most prominent precipitate (No. 16) and platelet fibrinogen (No 24) were not detected whereas in one patient with type II thromblasthenia, fibrinogen was normally detected and the amount of protein 16 was around 15% of the normal level. The alloantibody IgG L..., able to induce a "thrombasthenic-like" reactivity in normal human platelets, has been shown to be directed against protein 16.     

Binding of 3,3',5'-triiodo-L-thyronine (rT3) to human serum proteins]

The rT3-binding and human serum proteins was directly studied with tracer doses of radioactive rT3. Polyacrylamide gel electrophoresis showed 125I-rT3 added to human serum was distributed among two proteins: albumin (carrying 57% of tracer rT3) and TBPA )22%). No binding was observed to TBG, protein binding T4.     

金丝桃素抑制慢性病毒性心肌炎小鼠心肌细胞凋亡及Fas／FasL蛋白表达

目的观察金丝桃素对慢性病毒性心肌炎（VMC）小鼠心肌细胞凋亡及Fas／FasL蛋白表达的影响。方法Balb／C小鼠多次接种心肌柯萨奇段病毒复制慢性VMC模型,首次感染病毒45天后将存活小鼠分为模型组、金丝桃素组及氯沙坦组,同时设正常对照组．分别给予相应药物干预30天,采用原位末端标记法检测心肌细胞凋亡及免疫组化方法检测Fas／FasL蛋白表达。结果模型组心肌细胞凋亡率较正常组显著增加（P〈0．05）,金丝桃素组和氯沙坦组凋亡率较模型组显著降低（P〈0．05）。模型组Fas／FasL蛋白表达较正常组显著增多（P〈0．01）,金丝桃素组和氯沙坦组较模型组显著降低（P〈0．01）。结论金丝桃素保护心肌细胞与抑制VMC心肌细胞的凋亡．下调Fas／FasL蛋白表达有关。     

Immunoglobulin light chains, glycosaminoglycans, and amyloid

Immunoglobulin light chains are the precursor proteins for fibrils that are formed during primary amyloidosis and in amyloidosis associated with multiple myeloma. As found for the approximately 20 currently described forms of focal, localized, or systemic amyloidoses, light chain-related fibrils extracted from physiological deposits are invariably associated with glycosaminoglycans, predominantly heparan sulfate. Other amyloid-related proteins are either structurally normal, such as beta2-microglobulin and islet amyloid polypeptide, fragments of normal proteins such as serum amyloid A protein or the precursor protein of the beta peptide involved in Alzheimer's disease, or are inherited forms of single amino acid variants of a normal protein such as found in the familial forms of amyloid associated with transthyretin. In contrast, the primary structures of light chains involved in fibril formation exhibit extensive mutational diversity rendering some proteins highly amyloidogenic and others non-pathological. The interactions between light chains and glycosaminoglycans are also affected by amino acid variation and may influence the clinical course of disease by enhancing fibril stability and contributing to resistance to protease degradation. Relatively little is currently known about the mechanisms by which glycosaminoglycans interact with light chains and light-chain fibrils. It is probable that future studies of this uniquely diverse family of proteins will continue to shed light on the processes of amyloidosis, and contribute as well to a greater understanding of the normal physiological roles of glycosaminoglycans.     

尿毒症患者血清对内皮细胞小凹蛋白-1的影响及意义

目的体外观察尿毒症患者血液透析前后血清和健康人血清对人脐静脉内皮细胞(humanumbilicalveinendothelialcell, HUVECs)小凹蛋白 1(caveolin 1)表达的影响.方法取对数生长的 HUVECs,分为健康组(DMEM+健康人血清,n=8)、透前组(DMEM+尿毒症患者透前血清,n=18)、透后组(DMEM+尿毒症患者透后血清,n=18).采用 MTT法检测细胞活力,免疫组化SABC法和 Westernblot检测各组细胞内 caveolin 1蛋白的分布和含量.结果 MTT法筛选血清最佳干预时间和浓度分别为12小时、10%的血清干预浓度.与健康组比较,透前组细胞内 caveolin 1的蛋白表达水平明显下调(p<0.05),透后组改变不明显(p>0.05);而透后组细胞内 caveolin 1的蛋白表达水平较透前组细胞内 caveolin 1的蛋白表达水平上调(p<0.05).结论血液透析不能降低尿毒症患者动脉粥样硬化的形成的发生率,caveolin 1的变化可能是尿毒症血透患者动脉粥样硬化加速的原因之一     

S100A6 protein: functional roles

S100A6 protein belongs to the A group of the S100 protein family of Ca²⁺-binding proteins. It is expressed in a limited number of cell types in adult normal tissues and in several tumor cell types. As an intracellular protein, S100A6 has been implicated in the regulation of several cellular functions, such as proliferation, apoptosis, the cytoskeleton dynamics, and the cellular response to different stress factors. S100A6 can be secreted/released by certain cell types which points to extracellular effects of the protein. RAGE (receptor for advanced glycation endproducts) and integrin β1 transduce some extracellular S100A6’s effects. Dosage of serum S100A6 might aid in diagnosis in oncology.     

Immunochemical evidence for the specific binding of putrescine to plasma proteins including fibronectin

Human plasma contains proteins capable of binding 14C putrescine by the action of Ca++ activated transglutaminase. These proteins have molecular weights from 32 to 220 K and above. One of these (with a molecular weight of 220 K) has been identified as fibronectin by the use of an antifibronectin antiserum. Evidence for a protein with a molecular weight identical to that of fibronectin has been obtained on PAGE analysis of the precipitate formed on incubating human serum with antipolyamine antiserum.